These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33163854)

  • 21. Dyslipidemia and Thyroid Dysfunction Associated with Psoriasis.
    Rizal S; Joshi BR; Jha SK; Pradhan M; Regmi S
    J Nepal Health Res Counc; 2023 Jul; 20(4):1003-1007. PubMed ID: 37489693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of psoriasis as a systemic disease: what is the evidence?
    Korman NJ
    Br J Dermatol; 2020 Apr; 182(4):840-848. PubMed ID: 31225638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein Metabolism and Inflammation in Patients With Psoriasis.
    Armstrong EJ; Krueger JG
    Am J Cardiol; 2016 Aug; 118(4):603-9. PubMed ID: 27392508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does Systemic Anti-Psoriatic Treatment Impact the Risk of Cardiovascular Disease? A Review Over Cardiovascular Imaging Studies.
    Kaiser H; Näslund-Koch C; Kvist-Hansen A; Skov L
    Dermatol Ther (Heidelb); 2024 Feb; 14(2):303-321. PubMed ID: 38291285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The difference of lipid profiles between psoriasis with arthritis and psoriasis without arthritis and sex-specific downregulation of methotrexate on the apolipoprotein B/apolipoprotein A-1 ratio.
    Wang B; Deng H; Hu Y; Han L; Huang Q; Fang X; Yang K; Wu S; Zheng Z; Yawalkar N; Zhang Z; Yan K
    Arthritis Res Ther; 2022 Jan; 24(1):17. PubMed ID: 34996506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment.
    Bacchetti T; Campanati A; Ferretti G; Simonetti O; Liberati G; Offidani AM
    Br J Dermatol; 2013 May; 168(5):984-9. PubMed ID: 23614561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
    Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
    Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum lipid profile in psoriatic patients: correlation between vascular adhesion protein 1 and lipoprotein (a).
    Nemati H; Khodarahmi R; Rahmani A; Ebrahimi A; Amani M; Eftekhari K
    Cell Biochem Funct; 2013 Jan; 31(1):36-40. PubMed ID: 22753196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis.
    Dey AK; Gaddipati R; Elnabawi YA; Ongstad E; Goyal A; Chung JH; Teague HL; Rodante JA; Sajja AA; Sorokin AV; Lateef SS; Aksentijevich M; Choi H; Reddy AS; Varghese NJ; Groenendyk J; Belur AD; Genovese L; Rivers JP; Lerman J; Kabbany MT; Harrington C; Ortiz J; Khalil N; Keel A; Baumer Y; Chen MY; Bluemke DA; Joshi AA; Kaplan MJ; Remaley AT; Playford MP; Karathanasis SK; Gelfand JM; Gupta R; Mehta NN
    JAMA Dermatol; 2020 Feb; 156(2):151-157. PubMed ID: 31746956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essential polyunsaturated fatty acids, inflammation, atherosclerosis and cardiovascular diseases.
    De Lorgeril M
    Subcell Biochem; 2007; 42():283-97. PubMed ID: 17612056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiological Alterations of Redox Signaling and Endocannabinoid System in Granulocytes and Plasma of Psoriatic Patients.
    Ambrożewicz E; Wójcik P; Wroński A; Łuczaj W; Jastrząb A; Žarković N; Skrzydlewska E
    Cells; 2018 Oct; 7(10):. PubMed ID: 30301214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriatic skin inflammation induces a pre-diabetic phenotype via the endocrine actions of skin secretome.
    Evans EA; Sayers SR; Kodji X; Xia Y; Shaikh M; Rizvi A; Frame J; Brain SD; Philpott MP; Hannen RF; Caton PW
    Mol Metab; 2020 Nov; 41():101047. PubMed ID: 32599074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis.
    Lima Ede A; Lima MM; Marques CD; Duarte AL; Pita Ida R; Pita MG
    An Bras Dermatol; 2013; 88(6):1029-35. PubMed ID: 24474126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atherogenesis in Psoriasis: Evaluation of the Serum Activities of Non-high-density Lipoprotein Cholesterol and Other Lipids Among Newly Diagnosed Psoriasis Patients.
    Thungaturthi S; Vadakedath S; Pavuluri P; Rani J; Gundu R; Bheem J; Kandi V
    Cureus; 2019 Mar; 11(3):e4203. PubMed ID: 31114722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways.
    Piaserico S; Orlando G; Messina F
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis.
    Baumer Y; Ng Q; Sanda GE; Dey AK; Teague HL; Sorokin AV; Dagur PK; Silverman JI; Harrington CL; Rodante JA; Rose SM; Varghese NJ; Belur AD; Goyal A; Gelfand JM; Springer DA; Bleck CK; Thomas CL; Yu ZX; Winge MC; Kruth HS; Marinkovich MP; Joshi AA; Playford MP; Mehta NN
    JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioactive Lipid Mediator Profiles in Human Psoriasis Skin and Blood.
    Sorokin AV; Domenichiello AF; Dey AK; Yuan ZX; Goyal A; Rose SM; Playford MP; Ramsden CE; Mehta NN
    J Invest Dermatol; 2018 Jul; 138(7):1518-1528. PubMed ID: 29454560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Context-Dependent Role of Oxidized Lipids and Lipoproteins in Inflammation.
    Miller YI; Shyy JY
    Trends Endocrinol Metab; 2017 Feb; 28(2):143-152. PubMed ID: 27931771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum lipid metabolism in psoriasis and psoriatic arthritis - an update.
    Pietrzak A; Chabros P; Grywalska E; Kiciński P; Pietrzak-Franciszkiewicz K; Krasowska D; Kandzierski G
    Arch Med Sci; 2019 Mar; 15(2):369-375. PubMed ID: 30899289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of proresolving and inflammatory lipid mediators in human psoriasis.
    Sorokin AV; Norris PC; English JT; Dey AK; Chaturvedi A; Baumer Y; Silverman J; Playford MP; Serhan CN; Mehta NN
    J Clin Lipidol; 2018; 12(4):1047-1060. PubMed ID: 29730187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.